hGH fragment raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
== Career == Upon his return to Los Angeles, a childhood friend (88rising artist August 08) brought him along to studio sessions, where he rose to making beats for Duckwrth, Wale, Kehlani and others. In 2018 "Controller" received airplay on BBC Radio 1, and an Essential New Tune call-out from Pete Tong. Australian radio station Triple J added "Controller" to their A-list rotation and called it "one of 2018's biggest cult hits." Channel Tres continued to see success with the release of his self-titled EP in 2018 and further singles, including his single "Black Moses", which featured JPEGMAFIA. He played his first headline shows in the US in 2019.
=== Portugal === The Portuguese parliament is called the Assembleia da República. A member of parliament is known as a deputado, that is, a person who is appointed through democratic election to act on the people's behalf.
=== Historical taxonomy === The taxonomic history of Xanthoria parietina begins in 1753 with Carl Linnaeus, who first described it as Lichen parietinus in his landmark work Species Plantarum. In his brief diagnosis, Linnaeus characterized it as a foliose lichen with curled yellowish-brown lobes and a matching surface, citing Dillenius's earlier depiction and noting its broad European distribution on walls, rocks, and wood. Linnaeus's original specimens of Lichen parietinus are preserved in the Linnaean Herbarium (LINN), both labeled with his Species Plantarum number 25. These specimens have caused taxonomic confusion, as one actually corresponds to Rusavskia elegans (formerly Xanthoria elegans), while the other has features resembling Xanthoria ectaneoides. A separate specimen in his Flora Suecica collection was later reassigned to X. parietina. Due to these inconsistencies, taxonomists designated the illustration cited by Linnaeus from Dillenius (1742) as the lectotype, with a corresponding specimen in the Oxford herbarium (OXF) designated epitype.
Mabalirajan, Nahid Ali, Arun Bandyopadhyay, Aditya Konar, J. B. Chakraborty, I. C. Mukherjee, Jaydeep Chaudhuri, Sanjit Kumar Mahato, A. Manna, Roma Sinha, Pradyot Bhattacharya, J. Vinayagam, D. P. Jana, Sudeshna Chowdhury (January 2012). "Substituted catechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma (WO Patent 2,012,140,574.)". doi:10.13140/RG.2.1.2784.6488. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link) 1st Subhendu Bandyopadhyay, B. Ghosh, Parasuraman Jaisankar, Bikas C Pal, Siddhartha Roy, Nath Paul, Arjun Ram, U. Mabalirajan, Nahid Ali, Arun Bandyopadhyay, Aditya Konar, J. Bagchi Chakraborty, I. Choudhury Mukherjee, Jaydeep Chaudhuri, Sanjit Kumar Mahato, A. Manna, Roma Sinha, Pradyot Bhattacharya, J. Vinayagam, D. P. Jana, Sudeshna Chowdhury (April 2011). "Inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma (Patent 1032DEL2011)". {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
== Public reaction == After the trial, a Change.org petition requesting clemency for Vaught quickly garnered over 200,000 signatures. In response to the public backlash, the prosecutor's office issued a statement in which it defended its decision to prosecute Vaught: "The jury's conviction of Radonda Vaught was not an indictment against the nursing profession or the medical community. This case was, and always has been about the gross neglect by Radonda Vaught that caused the death of Charlene Murphey." Nursing unions and other concerned organizations issued statements warning that Vaught's prosecution could set a precedent for criminalizing honest medical errors and lead to compromised patient care due to medical workers failing to report their errors out of fear of severe punishment. Janie Harvey Garner of Show Me Your Stethoscope, a nurse advocacy group, said that Vaught's case undermined the practice of just culture, which seeks to improve health care by not penalizing health care workers who are transparent about mistakes and near mistakes. The "just culture" philosophy has been adopted by hospitals since a 1999 study by the National Academy of Medicine found that 98,000 people may have been dying due to medical errors annually.
Sources: en.wikipedia.org
Green: unwilted and unoxidized; Yellow: unwilted and unoxidized but allowed to yellow; White: wilted and unoxidized; Oolong: wilted, bruised, and partially oxidized; Black: wilted, sometimes crushed, and fully oxidized (called 紅茶 [hóngchá], "red tea" in Chinese and other East Asian tea culture); Post-fermented (Dark): green tea that has been allowed to ferment/compost (called Pu'er if from the Yunnan district of South-Western China or 黑茶 [hēichá] "black tea" in Chinese tea culture).
Glutathione synthesis In 1970, a former colleague, Dan Mohler, referred her to a family with a glutathione synthetase deficiency, leading her to develop and perform biochemical assays to elucidate the glutathione synthesis pathway.
=== Localization in cell and morphogenetic role === In 1933, while studying virgin sea urchin eggs, Jean Brachet suggested that DNA is found in the cell nucleus and that RNA is present exclusively in the cytoplasm. At the time, "yeast nucleic acid" (RNA) was thought to occur only in plants, while "thymus nucleic acid" (DNA) only in animals. The latter was thought to be a tetramer, with the function of buffering cellular pH. During the 1930s, Joachim Hämmerling conducted experiments with Acetabularia in which he began to distinguish the contributions of the nucleus and the cytoplasm substances (later discovered to be DNA and messenger RNA (mRNA), respectively) to cell morphogenesis and development.
==== Banking reform ==== In 1999, Sanders voted and advocated against rolling back the Glass–Steagall legislation provisions that kept investment banks and commercial banks separate entities. He was a vocal critic of Federal Reserve chair Alan Greenspan; in June 2003, during a question-and-answer discussion, Sanders told him he was concerned that he was "way out of touch" and "that you see your major function in your position as the need to represent the wealthy and large corporations."
==== Season 1 ==== The following table represents viewership data for each episode's airing on The CW, as DC Universe did not release viewership information. The pilot episode was tied for the second-best series debut on The CW for the 2019–20 television season with Nancy Drew after Batwoman, and was the best summer series premiere on the network since Whose Line Is It Anyway? season nine in 2013. Through the first seven episodes of the season, Stargirl was averaging a 0.2 rating for adults 18–49 and close to 1 million initial viewers per episode, which was "on par" with The CW's Arrowverse series.
Sources: en.wikipedia.org
== Notes == ^α Three countries - Mauritius, Saint Lucia, and Saudi Arabia - have not had figures reported by the FAO since the 1990s but are still included in the data; all three continue to produce coffee at a small scale. They are counted here as producing nations but not included in the global totals. ^β Values for China are estimated by the ICO.
== Discovery == The original discovery of Substance P (SP) was in 1931 by Ulf von Euler and John H. Gaddum as a tissue extract that caused intestinal contraction in vitro. Its tissue distribution and biologic actions were further investigated over the following decades. The eleven-amino-acid structure of the peptide was determined by Chang, et al. in 1971. In 1983, Neurokinin A (previously known as substance K or neuromedin L) was isolated from porcine spinal cord and was also found to stimulate intestinal contraction.
In March 2007, in the final verdict by the Supreme Court of Cassation, stated that "in the years of 1994 to 1998 there was no ascertained positive case of doping substances by Juventus players, that the purchase of erythropoietin or its administration to the athletes of the club does not emerge from any act of the trial, and that the same expert had identified the possibility of an administration of erythropoietin in distant terms from the sure evidence ("very probable" and in two cases "practically certain"): it is that therefore, the judgement of probability and not of certainty, did not allow for a statement of responsibility." The verdict also went on to say: "In response to the conclusion taken, the territorial court notes that there were no deferred values higher than the limits set in the various antidoping protocols and that the situation of the Juventus players, both with reference to the average hematological values, and in relation to that of material balance, did not differ from the national average population.
"When combined with the federal debt (approximately $680 billion), the debt-to-GDP ratio for Ontarians nears 80 percent." In October 2019, the Financial Accountability Office said that the deficit had increased from $ 3.7 billion in 2017—at the end of the Liberal administration—to $7.4 billion in 2018 under Premier Ford. The deficit had almost doubled partly because of "cancelled climate-change initiatives and subsidizing hydro bills" according to the Hamilton Spectator. The government's 2025 budget reported a $14.6 billion deficit; in 2026, the Ford government's budget deficit was nearly double what was projected in 2025, reaching $13.8 billion.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.